基本信息:
- 专利标题: ANTIBODIES AGAINST SOLUBLE BCMA
- 申请号:PCT/US2019/053433 申请日:2019-09-27
- 公开(公告)号:WO2020069303A1 公开(公告)日:2020-04-02
- 发明人: KIELCZEWSKA, Agnieszka , CHAN, Brian
- 申请人: AMGEN INC.
- 申请人地址: One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 专利权人: AMGEN INC.
- 当前专利权人: AMGEN INC.
- 当前专利权人地址: One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 代理机构: JANULIS, Lynn, L.
- 优先权: US62/738,997 20180928
- 主分类号: C07K16/28
- IPC分类号: C07K16/28 ; G01N33/574
摘要:
The present invention relates to antibodies that bind to soluble BCMA (sBCMA). Moreover, the invention relates to a detection system comprising such antibodies. The antibodies or the detection system may be used for detecting or quantifying sBCMA, for diagnosing a disease associated with sBCMA, for patient stratification, monitoring disease progression, and evaluating the therapeutic response.
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07K | 肽 |
------C07K16/00 | 免疫球蛋白,例如,单克隆或多克隆抗体 |
--------C07K16/18 | .来自动物或人的抵抗物质 |
----------C07K16/28 | ..抗受体,细胞表面抗原或细胞表面决定因子 |